[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Hepatitis A Vaccine Market Report 2016

December 2016 | 102 pages | ID: EBD8E29D558EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Hepatitis A Vaccine

Revenue, means the sales value of Hepatitis A Vaccine

This report studies sales (consumption) of Hepatitis A Vaccine in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • GlaxoSmithKline
  • MERCK SHARP & DOHME CORP
  • SANOFI PASTEUR
  • NORVATIS
  • CRUCELL
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Hepatitis A Vaccine in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on sales, market share and growth rate of Hepatitis A Vaccine in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Europe Hepatitis A Vaccine Market Report 2016

1 HEPATITIS A VACCINE OVERVIEW

1.1 Product Overview and Scope of Hepatitis A Vaccine
1.2 Classification of Hepatitis A Vaccine
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Hepatitis A Vaccine
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Hepatitis A Vaccine Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Hepatitis A Vaccine (2011-2021)
  1.5.1 Europe Hepatitis A Vaccine Sales and Growth Rate (2011-2021)
  1.5.2 Europe Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)

2 EUROPE HEPATITIS A VACCINE BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Hepatitis A Vaccine Market Competition by Manufacturers
  2.1.1 Europe Hepatitis A Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Hepatitis A Vaccine Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Hepatitis A Vaccine (Volume and Value) by Type
  2.2.1 Europe Hepatitis A Vaccine Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Hepatitis A Vaccine Revenue and Market Share by Type (2011-2016)
2.3 Europe Hepatitis A Vaccine (Volume and Value) by Countries
  2.3.1 Europe Hepatitis A Vaccine Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Hepatitis A Vaccine Revenue and Market Share by Countries (2011-2016)
2.4 Europe Hepatitis A Vaccine (Volume) by Application

3 GERMANY HEPATITIS A VACCINE (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Hepatitis A Vaccine Sales and Value (2011-2016)
  3.1.1 Germany Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
  3.1.2 Germany Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Hepatitis A Vaccine Sales Price Trend (2011-2016)
3.2 Germany Hepatitis A Vaccine Sales and Market Share by Manufacturers
3.3 Germany Hepatitis A Vaccine Sales and Market Share by Type
3.4 Germany Hepatitis A Vaccine Sales and Market Share by Application

4 FRANCE HEPATITIS A VACCINE (VOLUME, VALUE AND SALES PRICE)

4.1 France Hepatitis A Vaccine Sales and Value (2011-2016)
  4.1.1 France Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
  4.1.2 France Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
  4.1.4 France Hepatitis A Vaccine Sales Price Trend (2011-2016)
4.2 France Hepatitis A Vaccine Sales and Market Share by Manufacturers
4.3 France Hepatitis A Vaccine Sales and Market Share by Type
4.4 France Hepatitis A Vaccine Sales and Market Share by Application

5 UK HEPATITIS A VACCINE (VOLUME, VALUE AND SALES PRICE)

5.1 UK Hepatitis A Vaccine Sales and Value (2011-2016)
  5.1.1 UK Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
  5.1.2 UK Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
  5.1.5 UK Hepatitis A Vaccine Sales Price Trend (2011-2016)
5.2 UK Hepatitis A Vaccine Sales and Market Share by Manufacturers
5.3 UK Hepatitis A Vaccine Sales and Market Share by Type
5.4 UK Hepatitis A Vaccine Sales and Market Share by Application

6 RUSSIA HEPATITIS A VACCINE (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Hepatitis A Vaccine Sales and Value (2011-2016)
  6.1.1 Russia Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
  6.1.2 Russia Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Hepatitis A Vaccine Sales Price Trend (2011-2016)
6.2 Russia Hepatitis A Vaccine Sales and Market Share by Manufacturers
6.3 Russia Hepatitis A Vaccine Sales and Market Share by Type
6.4 Russia Hepatitis A Vaccine Sales and Market Share by Application

7 ITALY HEPATITIS A VACCINE (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Hepatitis A Vaccine Sales and Value (2011-2016)
  7.1.1 Italy Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
  7.1.2 Italy Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Hepatitis A Vaccine Sales Price Trend (2011-2016)
7.2 Italy Hepatitis A Vaccine Sales and Market Share by Manufacturers
7.3 Italy Hepatitis A Vaccine Sales and Market Share by Type
7.4 Italy Hepatitis A Vaccine Sales and Market Share by Application

8 SPAIN HEPATITIS A VACCINE (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Hepatitis A Vaccine Sales and Value (2011-2016)
  8.1.1 Spain Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
  8.1.2 Spain Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Hepatitis A Vaccine Sales Price Trend (2011-2016)
8.2 Spain Hepatitis A Vaccine Sales and Market Share by Manufacturers
8.3 Spain Hepatitis A Vaccine Sales and Market Share by Type
8.4 Spain Hepatitis A Vaccine Sales and Market Share by Application

9 BENELUX HEPATITIS A VACCINE (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Hepatitis A Vaccine Sales and Value (2011-2016)
  9.1.1 Benelux Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Hepatitis A Vaccine Sales Price Trend (2011-2016)
9.2 Benelux Hepatitis A Vaccine Sales and Market Share by Manufacturers
9.3 Benelux Hepatitis A Vaccine Sales and Market Share by Type
9.4 Benelux Hepatitis A Vaccine Sales and Market Share by Application

10 EUROPE HEPATITIS A VACCINE MANUFACTURERS ANALYSIS

10.1 GlaxoSmithKline
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Hepatitis A Vaccine Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 GlaxoSmithKline Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 MERCK SHARP & DOHME CORP
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Hepatitis A Vaccine Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 MERCK SHARP & DOHME CORP Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 SANOFI PASTEUR
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Hepatitis A Vaccine Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 SANOFI PASTEUR Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 NORVATIS
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Hepatitis A Vaccine Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 NORVATIS Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 CRUCELL
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Hepatitis A Vaccine Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 CRUCELL Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview

11 HEPATITIS A VACCINE MANUFACTURING COST ANALYSIS

11.1 Hepatitis A Vaccine Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Hepatitis A Vaccine

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Hepatitis A Vaccine Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Hepatitis A Vaccine Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE HEPATITIS A VACCINE MARKET FORECAST (2016-2021)

14.1 Germany Hepatitis A Vaccine Sales Forecast (2016-2021)
14.2 France Hepatitis A Vaccine Sales Forecast (2016-2021)
14.3 UK Hepatitis A Vaccine Sales Forecast (2016-2021)
14.4 Russia Hepatitis A Vaccine Sales Forecast (2016-2021)
14.5 Italy Hepatitis A Vaccine Sales Forecast (2016-2021)
14.6 Spain Hepatitis A Vaccine Sales Forecast (2016-2021)
14.7 Benelux Hepatitis A Vaccine Sales Forecast (2016-2021)
14.8 Europe Hepatitis A Vaccine Sales Forecast by Type (2016-2021)
14.9 Europe Hepatitis A Vaccine Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Hepatitis A Vaccine
Table Classification of Hepatitis A Vaccine
Figure Europe Sales Market Share of Hepatitis A Vaccine by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Hepatitis A Vaccine
Figure Europe Sales Market Share of Hepatitis A Vaccine by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Figure France Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Figure UK Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Figure Russia Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Figure Italy Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Figure Spain Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Figure Benelux Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Figure Europe Hepatitis A Vaccine Sales and Growth Rate (2011-2021)
Figure Europe Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Table Europe Hepatitis A Vaccine Sales of Key Manufacturers (2015 and 2016)
Table Europe Hepatitis A Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Hepatitis A Vaccine Sales Share by Manufacturers
Figure 2016 Hepatitis A Vaccine Sales Share by Manufacturers
Table Europe Hepatitis A Vaccine Revenue by Manufacturers (2015 and 2016)
Table Europe Hepatitis A Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Hepatitis A Vaccine Revenue Share by Manufacturers
Table 2016 Europe Hepatitis A Vaccine Revenue Share by Manufacturers
Table Europe Hepatitis A Vaccine Sales and Market Share by Type (2011-2016)
Table Europe Hepatitis A Vaccine Sales Share by Type (2011-2016)
Figure Sales Market Share of Hepatitis A Vaccine by Type (2011-2016)
Figure Europe Hepatitis A Vaccine Sales Growth Rate by Type (2011-2016)
Table Europe Hepatitis A Vaccine Revenue and Market Share by Type (2011-2016)
Table Europe Hepatitis A Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Hepatitis A Vaccine by Type (2011-2016)
Figure Europe Hepatitis A Vaccine Revenue Growth Rate by Type (2011-2016)
Table Europe Hepatitis A Vaccine Sales and Market Share by Countries (2011-2016)
Table Europe Hepatitis A Vaccine Sales Share by Countries (2011-2016)
Figure Sales Market Share of Hepatitis A Vaccine by Countries (2011-2016)
Table Europe Hepatitis A Vaccine Revenue and Market Share by Countries (2011-2016)
Table Europe Hepatitis A Vaccine Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Hepatitis A Vaccine by Countries (2011-2016)
Table Europe Hepatitis A Vaccine Sales and Market Share by Application (2011-2016)
Table Europe Hepatitis A Vaccine Sales Share by Application (2011-2016)
Figure Sales Market Share of Hepatitis A Vaccine by Application (2011-2016)
Figure Germany Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
Figure Germany Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
Figure Germany Hepatitis A Vaccine Sales Price Trend (2011-2016)
Table Germany Hepatitis A Vaccine Sales by Manufacturers (2015 and 2016)
Table Germany Hepatitis A Vaccine Market Share by Manufacturers (2015 and 2016)
Table Germany Hepatitis A Vaccine Sales by Type (2015 and 2016)
Table Germany Hepatitis A Vaccine Market Share by Type (2015 and 2016)
Table Germany Hepatitis A Vaccine Sales by Application (2015 and 2016)
Table Germany Hepatitis A Vaccine Market Share by Application (2015 and 2016)
Figure France Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
Figure France Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
Figure France Hepatitis A Vaccine Sales Price Trend (2011-2016)
Table France Hepatitis A Vaccine Sales by Manufacturers (2015 and 2016)
Table France Hepatitis A Vaccine Market Share by Manufacturers (2015 and 2016)
Table France Hepatitis A Vaccine Sales by Type (2015 and 2016)
Table France Hepatitis A Vaccine Market Share by Type (2015 and 2016)
Table France Hepatitis A Vaccine Sales by Application (2015 and 2016)
Table France Hepatitis A Vaccine Market Share by Application (2015 and 2016)
Figure UK Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
Figure UK Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
Figure UK Hepatitis A Vaccine Sales Price Trend (2011-2016)
Table UK Hepatitis A Vaccine Sales by Manufacturers (2015 and 2016)
Table UK Hepatitis A Vaccine Market Share by Manufacturers (2015 and 2016)
Table UK Hepatitis A Vaccine Sales by Type (2015 and 2016)
Table UK Hepatitis A Vaccine Market Share by Type (2015 and 2016)
Table UK Hepatitis A Vaccine Sales by Application (2015 and 2016)
Table UK Hepatitis A Vaccine Market Share by Application (2015 and 2016)
Figure Russia Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
Figure Russia Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
Figure Russia Hepatitis A Vaccine Sales Price Trend (2011-2016)
Table Russia Hepatitis A Vaccine Sales by Manufacturers (2015 and 2016)
Table Russia Hepatitis A Vaccine Market Share by Manufacturers (2015 and 2016)
Table Russia Hepatitis A Vaccine Sales by Type (2015 and 2016)
Table Russia Hepatitis A Vaccine Market Share by Type (2015 and 2016)
Table Russia Hepatitis A Vaccine Sales by Application (2015 and 2016)
Table Russia Hepatitis A Vaccine Market Share by Application (2015 and 2016)
Figure Italy Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
Figure Italy Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
Figure Italy Hepatitis A Vaccine Sales Price Trend (2011-2016)
Table Italy Hepatitis A Vaccine Sales by Manufacturers (2015 and 2016)
Table Italy Hepatitis A Vaccine Market Share by Manufacturers (2015 and 2016)
Table Italy Hepatitis A Vaccine Sales by Type (2015 and 2016)
Table Italy Hepatitis A Vaccine Market Share by Type (2015 and 2016)
Table Italy Hepatitis A Vaccine Sales by Application (2015 and 2016)
Table Italy Hepatitis A Vaccine Market Share by Application (2015 and 2016)
Figure Spain Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
Figure Spain Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
Figure Spain Hepatitis A Vaccine Sales Price Trend (2011-2016)
Table Spain Hepatitis A Vaccine Sales by Manufacturers (2015 and 2016)
Table Spain Hepatitis A Vaccine Market Share by Manufacturers (2015 and 2016)
Table Spain Hepatitis A Vaccine Sales by Type (2015 and 2016)
Table Spain Hepatitis A Vaccine Market Share by Type (2015 and 2016)
Table Spain Hepatitis A Vaccine Sales by Application (2015 and 2016)
Table Spain Hepatitis A Vaccine Market Share by Application (2015 and 2016)
Figure Benelux Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
Figure Benelux Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
Figure Benelux Hepatitis A Vaccine Sales Price Trend (2011-2016)
Table Benelux Hepatitis A Vaccine Sales by Manufacturers (2015 and 2016)
Table Benelux Hepatitis A Vaccine Market Share by Manufacturers (2015 and 2016)
Table Benelux Hepatitis A Vaccine Sales by Type (2015 and 2016)
Table Benelux Hepatitis A Vaccine Market Share by Type (2015 and 2016)
Table Benelux Hepatitis A Vaccine Sales by Application (2015 and 2016)
Table Benelux Hepatitis A Vaccine Market Share by Application (2015 and 2016)
Table Hepatitis A Vaccine Basic Information List
Table GlaxoSmithKline Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Hepatitis A Vaccine Sales Market Share (2011-2016)
Table MERCK SHARP & DOHME CORP Basic Information List
Table MERCK SHARP & DOHME CORP Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table MERCK SHARP & DOHME CORP Hepatitis A Vaccine Sales Market Share (2011-2016)
Table SANOFI PASTEUR Basic Information List
Table SANOFI PASTEUR Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table SANOFI PASTEUR Hepatitis A Vaccine Sales Market Share (2011-2016)
Table NORVATIS Basic Information List
Table NORVATIS Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table NORVATIS Hepatitis A Vaccine Sales Market Share (2011-2016)
Table CRUCELL Basic Information List
Table CRUCELL Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table CRUCELL Hepatitis A Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hepatitis A Vaccine
Figure Manufacturing Process Analysis of Hepatitis A Vaccine
Figure Hepatitis A Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Hepatitis A Vaccine Major Manufacturers in 2015
Table Major Buyers of Hepatitis A Vaccine
Table Distributors/Traders List
Figure Germany Hepatitis A Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure Germany Hepatitis A Vaccine Revenue and Growth Rate Forecast (2016-2021)
Figure France Hepatitis A Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure France Hepatitis A Vaccine Revenue and Growth Rate Forecast (2016-2021)
Figure UK Hepatitis A Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure UK Hepatitis A Vaccine Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Hepatitis A Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure Russia Hepatitis A Vaccine Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Hepatitis A Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure Italy Hepatitis A Vaccine Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Hepatitis A Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure Spain Hepatitis A Vaccine Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Hepatitis A Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Hepatitis A Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table Europe Hepatitis A Vaccine Sales Forecast by Type (2016-2021)
Table Europe Hepatitis A Vaccine Sales Forecast by Application (2016-2021)


More Publications